ArticleJournal of medicine and life2025
Predictive performance of the Zulfiqar Frailty Scale for 12-month morbidity and mortality in community-dwelling older adults attending general practice.
Article in Journal of medicine and life, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Frailty in older adults is a syndrome associated with increased morbidity and mortality. The Zulfiqar Frailty Scale (ZFS) was developed to facilitate the assessment of frailty in general practice. This study aimed to assess the predictive capacity of the ZFS over 12 months for events such as falls, hospitalizations, changes in treatment, and mortality. A prospective study was conducted in a general practice over a 12-month period. Patients aged 65 and over were included and assessed using the ZFS at T0 months, followed by assessment at T12 months. Data collected included demographic information, medical history, hemoglobin level over the last 3 months, and hemoglobin level at 12 months, as well as the occurrence of adverse events (falls, fractures, hospitalizations, and death). Statistical analyses were performed using ROC curves to determine the performance of the ZFS scale. Of the 135 patients included, 24% were considered frail at T0, and this figure rose to 28% at T12 months. The ZFS showed good predictive capacity for the occurrence of falls (AUC = 0.75) and hospitalizations (AUC = 0.64). Frail patients, according to the ZFS, had a significantly higher risk of falling (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.